Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome
Vian, A. W. E., Mohammed, O. M., Marwan, S. A. (2021). Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2020.12.005